PRS18 THE COST-EFFECTIVENESS OF ROFLUMILAST IN THE MANAGEMENT OF SEVERE COPD IN THE UK SETTING
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.779
https://www.valueinhealthjournal.com/article/S1098-3015(11)00918-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
247
First Page :
A140
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00918-1&doi=10.1016/j.jval.2011.02.779